Quest Diagnostics (DGX) Competitors $170.81 +3.40 (+2.03%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$170.86 +0.04 (+0.03%) As of 08/1/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DGX vs. HSIC, MEDP, AMN, LH, DVA, CHE, CRVL, AMED, MD, and CCRNShould you be buying Quest Diagnostics stock or one of its competitors? The main competitors of Quest Diagnostics include Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Labcorp (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), and Cross Country Healthcare (CCRN). Quest Diagnostics vs. Its Competitors Henry Schein Medpace AMN Healthcare Services Labcorp DaVita Chemed CorVel Amedisys Pediatrix Medical Group Cross Country Healthcare Henry Schein (NASDAQ:HSIC) and Quest Diagnostics (NYSE:DGX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings. Which has preferable valuation & earnings, HSIC or DGX? Quest Diagnostics has lower revenue, but higher earnings than Henry Schein. Quest Diagnostics is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHenry Schein$12.67B0.65$390M$3.2021.24Quest Diagnostics$9.87B1.93$871M$8.3520.46 Is HSIC or DGX more profitable? Quest Diagnostics has a net margin of 9.01% compared to Henry Schein's net margin of 3.21%. Quest Diagnostics' return on equity of 15.24% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Henry Schein3.21% 14.87% 5.82% Quest Diagnostics 9.01%15.24%6.64% Do insiders and institutionals hold more shares of HSIC or DGX? 96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend HSIC or DGX? Henry Schein presently has a consensus price target of $78.08, suggesting a potential upside of 14.86%. Quest Diagnostics has a consensus price target of $186.00, suggesting a potential upside of 8.89%. Given Henry Schein's higher probable upside, research analysts plainly believe Henry Schein is more favorable than Quest Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 0 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33Quest Diagnostics 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 2.67 Which has more risk & volatility, HSIC or DGX? Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Does the media prefer HSIC or DGX? In the previous week, Quest Diagnostics had 13 more articles in the media than Henry Schein. MarketBeat recorded 24 mentions for Quest Diagnostics and 11 mentions for Henry Schein. Quest Diagnostics' average media sentiment score of 1.12 beat Henry Schein's score of 0.99 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 18 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQuest Diagnostics beats Henry Schein on 12 of the 17 factors compared between the two stocks. Get Quest Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DGX vs. The Competition Export to ExcelMetricQuest DiagnosticsMED IndustryMedical SectorNYSE ExchangeMarket Cap$19.10B$3.68B$5.53B$20.47BDividend Yield1.87%1.38%4.74%3.71%P/E Ratio20.4633.3928.8829.04Price / Sales1.93151.02440.8757.15Price / Cash12.6520.7435.0722.46Price / Book2.634.218.254.43Net Income$871M$189.47M$3.25B$993.74M7 Day Performance1.44%-5.30%-3.75%-3.39%1 Month Performance-3.26%-6.08%4.26%-2.10%1 Year Performance13.87%-0.58%25.83%10.09% Quest Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DGXQuest Diagnostics4.9403 of 5 stars$170.81+2.0%$186.00+8.9%+15.7%$19.10B$9.87B20.4656,000Positive NewsAnalyst UpgradeInsider TradeHSICHenry Schein4.1314 of 5 stars$70.46-1.4%$78.08+10.8%-6.6%$8.58B$12.67B22.0225,000Upcoming EarningsMEDPMedpace4.1734 of 5 stars$453.05+1.2%$411.10-9.3%+9.8%$12.73B$2.23B33.685,900Analyst DowngradeInsider TradeAMNAMN Healthcare Services4.3814 of 5 stars$19.71-0.5%$32.08+62.8%-73.3%$754.42M$2.98B-4.552,968Upcoming EarningsLHLabcorp4.8997 of 5 stars$261.15-1.4%$285.00+9.1%+12.0%$21.86B$13.48B28.8270,000Insider TradeDVADaVita4.4426 of 5 stars$145.37+0.1%$167.40+15.2%+0.7%$10.98B$12.82B14.4176,000News CoveragePositive NewsUpcoming EarningsCHEChemed4.9713 of 5 stars$464.55-1.3%$596.67+28.4%-29.0%$6.80B$2.43B22.6315,695Trending NewsEarnings ReportAnalyst ForecastCRVLCorVel1.269 of 5 stars$88.07-0.8%N/A-15.2%$4.53B$895.59M47.955,075News CoverageUpcoming EarningsAMEDAmedisys2.9214 of 5 stars$96.91-1.1%$100.67+3.9%+0.4%$3.18B$2.37B35.7619,000Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeMDPediatrix Medical Group2.8786 of 5 stars$12.66+0.7%$16.67+31.6%+45.1%$1.09B$2.01B-12.534,305Upcoming EarningsCCRNCross Country Healthcare3.5842 of 5 stars$13.81+1.5%$17.93+29.8%-25.7%$452.69M$1.34B-26.068,205News Coverage Related Companies and Tools Related Companies Henry Schein Alternatives Medpace Alternatives AMN Healthcare Services Alternatives Labcorp Alternatives DaVita Alternatives Chemed Alternatives CorVel Alternatives Amedisys Alternatives Pediatrix Medical Group Alternatives Cross Country Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DGX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DGX Stock Alerts